Pefloxacin versus chloramphenicol in the therapy of typhoid fever
- 1 March 1995
- journal article
- clinical trial
- Published by Springer Nature in Infection
- Vol. 23 (2) , 103-106
- https://doi.org/10.1007/bf01833875
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever: A clinical and microbiological studyCurrent Therapeutic Research, 1992
- Fluoroquinolones in the treatment of typhoid fever and the carrier stateEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adultsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Comportement pharmacocinétique de la péfloxacine chez l'hommeLa Revue de Médecine Interne, 1986
- In-vitro activity of pefloxacin compared to other antibioticsJournal of Antimicrobial Chemotherapy, 1986
- In-vitro activity of pefloxacin against micro-organisms multiply resistant to -lactam antibiotics and aminoglycosidesJournal of Antimicrobial Chemotherapy, 1986
- Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humansAntimicrobial Agents and Chemotherapy, 1984
- SALMONELLA TYPHI IN VIVO ACQUIRES RESISTANCE TO BOTH CHLORAMPHENICOL AND CO-TRIMOXAZOLEThe Lancet, 1981
- CHLORAMPHENICOL-RESISTANT TYPHOID FEVER IN VIETNAM ASSOCIATED WITH R FACTORThe Lancet, 1973
- Transferable Chloramphenicol Resistance in Salmonella typhiNature, 1972